Dipna Pharmachem Balance Sheet Health
Financial Health criteria checks 4/6
Dipna Pharmachem has a total shareholder equity of ₹375.2M and total debt of ₹194.5M, which brings its debt-to-equity ratio to 51.8%. Its total assets and total liabilities are ₹1.3B and ₹953.9M respectively. Dipna Pharmachem's EBIT is ₹34.1M making its interest coverage ratio 1.7. It has cash and short-term investments of ₹138.8M.
Key information
51.8%
Debt to equity ratio
₹194.45m
Debt
Interest coverage ratio | 1.7x |
Cash | ₹138.78m |
Equity | ₹375.19m |
Total liabilities | ₹953.87m |
Total assets | ₹1.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 543594's short term assets (₹1.3B) exceed its short term liabilities (₹828.4M).
Long Term Liabilities: 543594's short term assets (₹1.3B) exceed its long term liabilities (₹125.5M).
Debt to Equity History and Analysis
Debt Level: 543594's net debt to equity ratio (14.8%) is considered satisfactory.
Reducing Debt: 543594's debt to equity ratio has reduced from 1230.6% to 51.8% over the past 5 years.
Debt Coverage: 543594's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 543594's interest payments on its debt are not well covered by EBIT (1.7x coverage).